Comments on “Preventive home therapy for symptomatic patients affected by COVID-19  and followed by teleconsultations” by D’Amato et al.

Girolamo Adiletta; Stefano Baglioni; Germano Bettoncelli; Pierluigi Bracciale; Mario Cazzola; Enrico M. Clini; Renato Cutrera; Franco D'Adduzio; Francesco De Blasio; Fausto Ferraro; Roberto Fumagalli; Cosimo Lequaglie; Maria Gabriella Matera; Fabio Numis; Paolo Palange; Stefano Picciolo; Alfredo Potena; Francesco Romano; Eugenio Sabato; Antonio Sacchetta; Mario Spatafora; Francesco Stefanelli; Carlo Zottola

doi:10.4081/mrm.2021.757

Comments on “Preventive home therapy for symptomatic patients affected by COVID-19 and followed by teleconsultations” by D’Amato et al.

Authors

Girolamo Adiletta General Medicine, “Villa Malta” Hospital, Salerno
Stefano Baglioni Pneumology Department, Perugia Hospital, Perugia https://orcid.org/0000-0002-5250-2868
Germano Bettoncelli General Practitioner, Brescia https://orcid.org/0000-0001-8883-0794
Pierluigi Bracciale Pneumology Department, "Ninetto Melli" Hospital, San Pietro V.co (BR)
Mario Cazzola Unit of Respiratory Medicine, Department of Experimental Medicine, University of Rome “Tor Vergata”, Rome https://orcid.org/0000-0003-4895-9707
Enrico M. Clini Respiratory Disease Unit, University Hospital of Modena and University of Modena Reggio Emilia https://orcid.org/0000-0002-1515-5094
Renato Cutrera Respiratory Unit, Academic Department of Pediatrics, Bambino Gesù Children's Hospital, IRCCS, Rome https://orcid.org/0000-0001-7711-5672
Franco D'Adduzio UO Territorial Pneumology - ASL BT, Barletta (BT)
Francesco De Blasio Respiratory Medicine and Pulmonary Rehabilitation Section, Clinic Center, Private Hospital, Naples; Department of Medicine and Health Sciences 'V. Tiberio', University of Molise, Campobasso https://orcid.org/0000-0002-1080-7049
Fausto Ferraro Department of Anesthetic, Surgical and Emergency Science, Second University of Naples
Roberto Fumagalli Department of Medicine and Surgery, University of Milano Bicocca, Department of Anesthesia and Intensive Care, Ospedale Niguarda, Milan
Cosimo Lequaglie Department of Thoracic Surgery, IRCCS-CROB Centro Riferimento Oncologico Basilicata, Rionero in Vulture (PZ) https://orcid.org/0000-0002-7284-3598
Maria Gabriella Matera Unit of Pharmacology, Department of Experimental Medicine, University of Campania “Luigi Vanvitelli”, Naples
Fabio Numis Emergency Department, Santa Maria delle Grazie Hospital, Naples https://orcid.org/0000-0002-3638-4072
Paolo Palange Department of Clinical and Molecular Medicine, Division of Respiratory Diseases, Umberto I Hospital, Sapienza University, Rome
Stefano Picciolo Unit of Respiratory Medicine, Department of Medical Sciences, University Hospital of Messina https://orcid.org/0000-0002-1953-4024
Alfredo Potena General Medicine, Casa di Cura S.M. Maddalena Private Hospital, Occhiobello (RO) https://orcid.org/0000-0002-6905-060X
Francesco Romano Respiratory Unit, Medical Center, Cosenza
Eugenio Sabato Pulmonology Ward, "A. Perrino" Hospital, Brindisi
Antonio Sacchetta General Medicine, San Camillo Hospital, Treviso https://orcid.org/0000-0003-2454-0581
Mario Spatafora Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo (retired) https://orcid.org/0000-0001-6821-5882
Francesco Stefanelli Department of Pneumology, Monaldi Hospital, Naples
Carlo Zottola Rehabilitation and Respiratory Section, INRCA-National Institute of Health and Sciences on Ageing, Cosenza https://orcid.org/0000-0003-0273-8351

DOI: https://doi.org/10.4081/mrm.2021.757

Keywords:

COVID-19, LMWH, steroids, home therapy

Abstract

We have read with interest the letter from D’Amato et al. entitled “Preventive home therapy for symptomatic patients affected by COVID-19 and followed by teleconsultations”....

References

D'Amato G, Acanfora L, Delli Paoli L, D'Amato M. Preventive home therapy for symptomatic patients affected by COVID-19 and followed by teleconsultations. Multidisc Respir Med 2021;16:748.

Pirro M. Covid, svolta con la terapia napoletana: «Medicinali subito e nessun decesso». Available from: https://www.ilmattino.it/primopiano/sanita/coronavirus_terapia_napoletana-5726333.html

Horby P, Lim WS, Emberson JR, et al. Dexamethasone in hospitalized patients with Covid-19 - Preliminary report. Epub 2020 Jul 17. N Engl J Med 2021;384:693-704.

Yang Z, Liu J, Zhou Y, et al. The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis. J Infect 2020;81:e13-e20.

Li H, Chen C, Hu F, et al. Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis. Leukemia 2020;34:1503-11.

Monedero P, Gea A, Castro P, Candela-Toha AM, Hernández-Sanz ML, Arruti E, et al. Early corticosteroids are associated with lower mortality in critically ill patients with COVID-19: a cohort study. Crit Care 2021;25:2.

Theoharides TC, Conti P. Dexamethasone for COVID-19? Not so fast. J Biol Regul Homeost Agents 2020;34:1241-3.

Khider L, Soudet S, Laneelle D, et al. Proposal of the French Society of Vascular Medicine for the prevention, diagnosis and treatment of venous thromboembolic disease in outpatients with COVID-19. J Med Vasc 2020;45:210-3.

Abdel-Maboud M, Menshawy A, Elgebaly A, Bahbah EI, El Ashal G, Negida A. Should we consider heparin prophylaxis in COVID-19 patients? a systematic review and meta-analysis. J Thromb Thrombolysis 2020. Online Ahead of Print.

National Institutes of Health. COVID-19 Treatment Guidelines. Antithrombotic Therapy in Patients with COVID-19. Last Updated: December 17, 2020. Available from: https://www.covid19treatmentguidelines.nih.gov/adjunctive-therapy/antithrombotic-therapy/

Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, et al. COVID-19 and thrombotic or thromboembolic disease: Implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. J Am Coll Cardiol 2020;75:2950–73.

Italian Medicines Agency (AIFA). Low molecular weight heparins in the treatment of adult patients with COVID-19. Update: 24 November 2020. Available from: https://www.aifa.gov.it/documents/20142/1267737/Low-molecular-weight-heparins_EN_24.11.2020.pdf/fc92d837-e27a-17af-18db-9a8635fb19d5